Medicare Enrolled

Dr. Amber Siegel, APRN

Q: Does Dr. Siegel receive payments from pharmaceutical companies?

Yes. Dr. Siegel received a total of $13,332 from 24 companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

Q: What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Siegel) measures how much public federal data is available about a provider. It is not a quality rating. A Very High or High level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A Low or Moderate level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative.

Infectious Disease · Orlando, FL

Low-engagement

1510 E COLONIAL DR STE 230, Orlando, FL 32803

3152869748

In practice since 2019 (7 years)

NPI: 1003371642 verify on NPPES ↗

Moderate

DATA COVERAGE

Data in 3 of 4 federal sources

Measures public federal data availability — not provider quality

Informational, not a quality rating. This page presents federal public records about Dr. Siegel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →

Are you Dr. Siegel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Siegel

Dr. Amber Siegel is an infectious disease specialist in Orlando, FL, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Siegel received a total of $13,332 from 24 pharmaceutical and/or device companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Siegel is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice $13,332 industry payments

Florida License Status

FL DOH · MQA

Active license

None

Board action on record

Recent admin complaints

Profession	License #	Status	Expires	Board Action
Advanced Practice Registered Nurse	11001385	Clear	July 31, 2026	—

Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Industry Payment Transparency

Open Payments through 2024 ↗

$13,332

Total received (2020-2024)

Avg $2,666/year across 5 years

Top 12% in FL for infectious disease

Companies

491

Individual payments

All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel

Food, beverages, travel, and lodging — typically low-value

$13,293 (99.7%)

Speaking / Promotional

Speaker programs, honoraria, and industry-sponsored educational events

$39 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024

$3,374

2023

$3,292

2022

$3,790

2021

$2,859

2020

$17

Payments by company (2024)

Consulting

Speaking

Meals & Travel

Research

ViiV Healthcare Company

$3,669

Gilead Sciences, Inc.

$2,814

ABBVIE INC.

$2,323

AbbVie Inc.

$852

Theratechnologies Inc.

$812

Janssen Biotech, Inc.

$409

Amgen Inc.

$406

Merck Sharp & Dohme LLC

$342

Antares Pharma, Inc.

$302

Lilly USA, LLC

$298

Napo Pharmaceuticals Inc

$248

EMD Serono, Inc.

$210

ITI, Inc.

$173

Paratek Pharmaceuticals, Inc.

$131

Hologic Sales and Service, LLC

$67

Merck Sharp & Dohme Corporation

$62

Acerus Pharmaceuticals Corporation

$39

Otsuka America Pharmaceutical, Inc.

$37

Tolmar, Inc.

$34

Novo Nordisk Inc

$33

Abbott Laboratories

$27

VYERA PHARMACEUTICALS, LLC

$17

AstraZeneca Pharmaceuticals LP

$15

Teva Pharmaceuticals USA, Inc.

$13

Top 3 companies account for 66.0% of total payments

Associated products mentioned in payments ›

ABILIFY MAINTENA · APRETUDE · APTIMA · AirDuo Digihaler · Biktarvy · CABENUVA · CAPLYTA · DELSTRIGO · DOVATO · Daraprim · Descovy · EGRIFTA · EGRIFTA SV · ELIGARD · FARXIGA · FREESTYLE LIBRE 3 · JATENZO · MAVYRET · MOUNJARO · Mytesi · NOCDURNA · NUZYRA · Natesto · Otezla · PIFELTRO · PREZCOBIX · QULIPTA · REXULTI · RUKOBIA · Repatha · Rybelsus · SEROSTIM · SYMTUZA · Sunlenca · TROGARZO · VRAYLAR · ZEPBOUND

Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Orlando?
Compare infectious diseases in the Orlando area by procedure volume, costs, and industry payment transparency.

Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi

Per 100K population

5.3

County median income

$77,011

Nearest hospital

ADVENTHEALTH ORLANDO
0.0 mi

Data Sources

Provider Registry	✓ NPPES	Weekly updates
Medicare Enrollment	✓ PECOS	Monthly updates
Practice Data	— No data	N/A
Industry Payments	✓ Open Payments	CY 2024
Disciplinary History	— Not public	N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Siegel is an infectious disease specialist, with low-engagement industry engagement in the top 12% of FL peers.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Siegel receive payments from pharmaceutical companies?

Yes. Dr. Siegel received a total of $13,332 from 24 companies across 491 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.

What does Data Coverage mean?

Data Coverage (currently Moderate for Dr. Siegel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →

Is this data up to date?

Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city

Infectious Diseases in Orlando

Browse infectious diseases in Orlando ranked by procedure volume and transparency data.

Highest volume

Top Infectious Diseases in FL

Infectious diseases ranked by total Medicare services performed statewide.

Industry payments

Pharma Payments to Infectious Diseases in FL

Which FL infectious diseases receive the most from drug and device companies.

By company

ViiV Healthcare Company Payments to Doctors

See all physicians who received payments from ViiV Healthcare Company.

By company

Gilead Sciences, Inc. Payments to Doctors

See all physicians who received payments from Gilead Sciences, Inc.

By company

ABBVIE INC. Payments to Doctors

See all physicians who received payments from ABBVIE INC.

About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology